Aldosterone in Heart Disease
- 5 February 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Hypertension Reports
- Vol. 14 (2), 125-129
- https://doi.org/10.1007/s11906-012-0256-9
Abstract
Numerous studies have now shown that sustained elevation of aldosterone levels induces cardiovascular damage independent from its effects on regulation of renal sodium and blood pressure. Increased aldosterone and cortisol levels in patients with heart failure independently predict the risk of mortality. Over the past decade, there has been increased interest in identifying the role of the receptor for aldosterone, the mineralocorticoid receptor (MR), following the results from the large clinical heart failure trials that showed low doses of MR antagonists reduced morbidity and mortality in heart failure and myocardial infarction, even though plasma levels of aldosterone were in the physiologic range. The mechanism for this cardioprotective action remains to be defined, although changes in the redox state have been shown to play a key role in MR-mediated cardiac damage. This review will highlight some of these studies and provide an update on the action of aldosterone in heart disease.Keywords
This publication has 36 references indexed in Scilit:
- Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarctionEuropean Journal of Heart Failure, 2011
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsNew England Journal of Medicine, 2011
- Aldosterone and long-term outcome after myocardial infarction: A substudy of the french nationwide Observatoire sur la Prise en charge hospitalière, l'Evolution à un an et les caRactéristiques de patients présentant un infArctus du myocarde avec ou sans onde Q (OPERA) studyAmerican Heart Journal, 2009
- Effect of Spironolactone on Blood Pressure in Subjects With Resistant HypertensionHypertension, 2007
- High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial InfarctionCirculation, 2006
- Efficacy of low-dose spironolactone in subjects with resistant hypertensionAmerican Journal of Hypertension, 2003
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertensionAmerican Journal of Hypertension, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den MineralstoffwechselCellular and Molecular Life Sciences, 1953